This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.
Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
Aged ≥ 18 years old
Diagnosis of hidradenitis suppurativa
Able to comprehend the investigational nature of the protocol and provide informed consent
Female patients who are currently pregnant or nursing
Inability to perform regular electronic reporting
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.